Olodon Free (Olopatadine)

Olopatadine is used to manage allergic conditions affecting the eye surface and related pathways.

• Allergic conjunctivitis: reduces redness, itching and watery discharge.
• Seasonal allergic rhinitis: alleviates nasal itching, sneezing and congestion.
• Chronic urticaria: helps control hives and associated itching.
• Atopic dermatitis: provides relief from skin itching and inflammation.
• Allergic keratoconjunctivitis: improves visual comfort and reduces ocular irritation.

• Olopatadine selectively blocks histamine H1 receptors on mast cells and basophils, preventing histamine‑mediated vasodilation and increased vascular permeability. It also exhibits mast‑cell stabilising activity, reducing the release of inflammatory mediators such as leukotrienes and prostaglandins, which contributes to its antiallergic effect.

Olopatadine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild and transient.
• Dry eye: temporary discomfort.
• Burning sensation: mild irritation at the application site.
• Blurred vision: short‑term visual disturbance.
• Taste disturbance: altered taste perception.
• Nasal irritation: mild congestion or itching.

Serious or Rare Side Effects

• Severe allergic reaction: rash, swelling, or difficulty breathing.
• Persistent eye inflammation: prolonged redness or pain.
• Vision loss: sudden decrease in visual acuity.
• Anaphylaxis: life‑threatening systemic reaction.
• Stevens‑Johnson syndrome: severe skin blistering.
• Corneal ulceration: ulcer formation on the cornea.

When using Olopataden, consider the following safety measures:

• Assess allergy history: verify whether the patient has known hypersensitivity to olopatadine or related compounds.
• Monitor ocular health: schedule regular eye examinations to detect any worsening of symptoms.
• Caution in pregnancy:  the risk of development to the fetus is uncertain and should be discuss c c the the the ");
• Use  the "); 

-  ");   -  

• Store  "); 

-  d . -  t . -  -  t. -  t. -  -  -  -  t. -  -  t. -  - \

• The      \